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1 Introduction  
The addition of monosodium glutamate (MSG), to mimic the natural flavour of the non-essential amino 
acid, glutamate, to most commercially processed foods could be extensive with possible threat to public 
health [1-6]. Health hazards of MSG could result to oxidative stress in animals [3,7-13]. And, oxidative 
A B S T R A CT  
This study aimed at assessing alterations in malondialdehyde, 
MDA, total protein and albumin concentration in the serum and 
liver homogenate of monosodium glutamate (MSG)-challenged 
rats co-treated with artemether-lumefantrine, AL. Methods 
involving colourimetric estimation were employed in thirty rats 
randomly grouped into six (n = 5) and for seven consecutive days, 
fed feed and water (Group A), AL therapeutic dose (Group B), AL 
overdose (therapeutic dose × 5) (Group C), MSG (8000 mg/kg 
body weight) (Group D), AL therapeutic dose plus MSG (Group 
E) or AL overdose plus MSG (Group F). Total protein 
concentration (2.64±0.09 g/dL, 2.81±0.14g/dL, respectively) in 
the liver homogenate of rats exposed to MSG (group D) or MSG 
plus AL overdose (group F) and malondialdehyde concentration in 
the liver homogenate of MSG plus AL overdose-fed rats 
(0.45±0.04 mg/ml) lowered (P<0.05) as against other groups. 
However, serum albumin concentration in MSG (2.59±0.13 g/dl) 
or AL overdose plus MSG (3.24±0.12 g/dl) fed rats was higher 
(P<0.05) compared to the control (2.02±0.04 g/dl). The Total 
protein: Albumin ratio lowered while the Albumin: total protein 
ratio increased in rats in MSG, AL overdose plus MSG or AL 
overdose groups compared with the control. Thus, the apparent 
MSG plus AL overdose-induced adverse influence on the studied 
parameters and samples of non-malarial infested rats could be via 
compromised liver-mediated protein metabolism capacity and bio-
functions following possibly enhanced protein-malondialdehyde 
adduct formation in the rats. 
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stress has been implicated in the pathogenesis of diverse diseases, including malaria that is endemic in poor 
areas [14-16]. Artemisinin-based combination therapies (ACTs) serve as first line anti-malarial in drug 
resistant malaria parasite which is endemic in sub-Saharan African countries [17-18]. Artemether-
lumefantrine, a common artemesisnin-based   combination therapy, acts by generating free radicals (pro-
oxidants) and reactive oxygen species that kill the malaria parasites [19-21] but with potential threat to many 
cells [13, 20-21]. 
The possible interaction of MSG with artemether-lumefantrine could exert significant influence on the 
oxidative stress parameters related to protein metabolism of animals, notably in the liver that detoxifies 
xenobiotics [23] aside metabolizing protein [24]. Oxidative stress was implicated in many diseased 
conditions [25,26] while abnormal protein metabolism could also result in animal health dysfunctions. 
Metabolic abnormalities could be detected in the associated bio-indicators in the serum and in high 
metabolic organs (including liver) homogenate. Furthermore, a possibility of abuse of AL exists as self-
medication with anti-malarial drugs has been reported [27]. Also, possibility of co-intake of artemether-
lumefantrine with overdose of monosodium glutamate-flavour enhanced fast foods in absence of malaria 
infection exists. Recently, in a similar study, Obi and Egbuonu [28] reported a significantly compromised 
liver morphology and antioxidant capacity.  
Notwithstanding the foregoing, there is paucity in literature as regards possible effect on the concentration 
of malondialdehyde, protein and albumin in the serum and liver homogenate following intake of AL either 
alone or in combination with intoxicating dose of MSG, warranting the present investigation. Altered liver 
bio-function could be detrimental to balanced physio-function. In particular, as a good bio-indicator of 
liver function, protein metabolism function and oxidative stress, malondialdehyde, one of the most 
abundant aldehyde products of lipid peroxidation, could react on cellular and tissue proteins to form 
adducts resulting to the alteration of protein function and attendant cellular responses [29]. And albumin, 
the most abundant blood protein produced in the liver that is important in regulating blood volume and in 
acting as carrier of non-enzymatic antioxidants including vitamin C, vitamin E and Glutathione serves as a 
good indicator of liver function and non-enzymatic antioxidant status. 
2 Materials and Methods 
The artemether-lumefantrine (20:120 mg) was purchased from a medical representative while monosodium 
glutamate (99 % purity) was purchased from a foodstuff market, in Umuaha Abia State, Nigeria. A total of 
thirty (30) male Wistar rats (89-183 g) were kept in the animal house of the Department of Biochemistry, 
Michael Okpara University of Agriculture, Umudike, Abia State, Nigeria for 14-day to acclimatize. 
Thereafter, the rats were randomly grouped into six (6) (n = five rats) and respectively allowed free access 
to feed and portable water. With a gavage, rats in the control group (Group A) were exposed to distilled 
water while those in Group B were exposed to AL therapeutic dose. Rats in Group C were exposed to AL 
overdose, calculated as therapeutic dose for 70 kg man multiplied by 5, while those in Group D were 
exposed to MSG. Rats in Group E were exposed to AL therapeutic dose plus MSG whereas those in Group 
F were exposed to AL overdose plus MSG. The artemether-lumefantrine administration was twice each 
day at 8 hrs interval [30]. Rats’ intoxication with MSG was achieved at 8000 mg/kg body weight and by 
daily exposure for 7 days [7, 31-34]. 
All rats used in this study were housed at 25 oC in stainless steel cages under normal daylight/day cycle. 
The rats were conditioned throughout the process according to the guidelines approved by the college cum 
departmental committee on animal use, Michael Okpara University of Agriculture, Umudike on handling 
of experimental rats. After 7 days, following overnight fast, the rats were sacrificed by ocular puncture. The 
blood sample of the respective rats was collected into a clean non-anticoagulated polystyrene tube, allowed 
to clot and centrifuged at 3000 rpm for 5 minutes. The resultant respective serum collected was separately 
refrigerated until used. The liver of the respective rat was excised, rinsed in iced-cold sucrose, and a 10 % 
w/v homogenate was prepared from it using 0.15 M KCl as buffer to obtain the supernatant sample after 
centrifugation [32]. 
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Total protein content in the rats’ serum and liver homogenate was determined using Peterson’s 
modifications of the Micro-Lowry method with a protein assay kit (Sigma Diagnostics, P 5656, Sigma, MO, 
USA) based on Buiret method.  The absorbance of the sample (Asample) and of the standard (Astandard) against 
the reagent blank was read at 546 nm. The MDA concentration in the rats’ serum and liver homogenate 
was determined by the method of Wallin et al. [35] based on the principles as described in Egbuonu and 
Ezeanyika [36] that malondialdehyde, MDA, resulting from lipid degradation reacts with thiobarbituric acid 
to form a red or pink coloured complex which in acid solution absorbs maximally at 532 nm. The 
absorbance was therefore taken at wavelength 532 nm and 600 nm against a blank and the MDA 
concentration calculated as the percentage thiobarbituric acid reacting substances (TBARS) using the 
relation: 
% 𝑇𝐵𝐴𝑅𝑆 =  
𝐴532 − 𝐴600  ×  100
0.571 ×  0.1
 (𝑚𝑔 𝑚𝑙⁄ ) 
Albumin concentration in the rats’ serum and liver homogenate was estimated using Bromocresol green 
(BCG) according to Doumas et al. [37] as reported recently [38]. In brief, this method was based on the 
principle that under acidic conditions, serum albumin binds specifically and quantitatively with the indicator 
3,3,5,5,-tetrabromo-m-cresolsulphonephthelein  (bromocresol green, BCG) to form a green coloured 
albumin-BCG complex that absorbs maximally at 578 nm,the absorbance being directly proportional to the 
concentration of albumin in the sample, and was measured colourimetrically at 640 nm. The albumin 
concentration in the sample was calculated from the following formula: 
Albumin Concentration (g/l or g/dl)  =  
𝐴𝑠𝑎𝑚𝑝𝑙𝑒
𝐴𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑
× Concentration of standard 
Diagnostic ratios (Total protein:Albumin and Albumin:total protein) in serum and liver homogenate of rats 
were calculated from the result of this study. The change relative to group was calculated using the relation: 
Change relative to K (%) = (V−K)/K×100  
where K is the constant group value and V is the variable group values [11,12,25, 31-34, 39-43]. The data 
were subjected to one-way analysis of variance (ANOVA) using Statistical package for social sciences 
(SPSS) version 20.0. Results were expressed as mean ± standard error of mean (SEM). Difference was 
significant at p< 0.05 and by a relative change of ten (10) per cent and above [42]. 
3 Results  
As shown in Table 1, the total protein concentration (g/dL) in the serum of rats exposed to AL therapeutic 
dose (3.62±0.22 g/dl,− 22.15 % relative to control), AL overdose (3.33±0.07g/dl, −28.39 % relative to 
control) and intoxicating dose of MSG (3.72±0.08g/dl, −20.00 % relative to control) respectively decreased 
(P<0.05) as compared to control (4.65±0.09g/dl). However, the decrease and increase respectively in the 
total protein concentration of rats’ serum concomitantly exposed to AL therapeutic dose and intoxicating 
dose of MSG (4.29±0.05g/dl, −7.74 % relative to control) and AL overdose together with intoxicating 
dose of MSG (4.70±0.18g/dl, +1.08 % relative to control) was not significant (P>0.05). 
Table 1: Total protein concentration (g/dL) in the serum of normal and monosodium glutamate-intoxicated rats 
co-treated with artemether-lumefantrine 
Group Total 
protein(g/dl) 
Changes relative to the 
control (%) 
Changes relative to the 
MSG group (%) 
A: Control (feed + water only) 4.65±0.09 0.00 +25.00 
B: AL therapeutic dose 3.62±0.22 −22.15 −2.69 
C: AL overdose 3.33±0.07 −28.39 −10.48 
D: MSG (8000mgkg-1bwt) 3.72±0.08 −20.00 0.00 
E: AL therapeutic dose + MSG 4.29±0.05 −7.74 +15.32 
F: AL overdose + MSG 4.70±0.18 +1.08 +26.34 
Values are mean±SEM for n=5. + denotes higher by; − denotes lower by. Difference considered statistically significant at p<0.05 and a 
relative change of ten (10) per cent and above [42]. 
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From Table 2, as compared with the control group (3.40±0.19 g/dl) there was a significant (P<0.05) 
decrease in the total protein (g/dl) in the liver homogenate of rats exposed to intoxicating dose of MSG, 
group D (2.64±0.09 g/dl, − 22.35 %) and in those exposed to AL overdose together with intoxicating dose 
of MSG, group F (2.81±0.14 g/dl, − 17.35 %), but an increase (P<0.05) in that of rats exposed to AL 
therapeutic dose, group B (4.10±0.05 g/dl, + 20.59 %) whereas there was a non-significant (P>0.05) 
decrease in the rats exposed to AL overdose, group C (3.03±0.27 g/dl, − 10.88 %)and in those exposed to 
AL therapeutic dose together with intoxicating dose of MSG, group E (3.04±0.23 g/dl, − 10.59 %). 
Table 2: Total protein concentration (g/dl) in the liver homogenate of normal and monosodium glutamate-
intoxicated rats co-treated with artemether-lumefantrine 
Group Total protein(g/dl) Changes relative to the 
control (%) 
Changes relative to the 
MSG group (%) 
A: Control (feed + water only) 3.40±0.19 0.00 +28.79 
B: AL therapeutic dose 4.10±0.05 +20.59 +55.30 
C: AL overdose 3.03±0.27 −10.88 +14.77 
D: MSG (8000mgkg-1bwt) 2.64±0.09 −22.35 0.00 
E: AL therapeutic dose + MSG 3.04±0.05 −10.59 +15.15 
F: AL overdose + MSG 2.81±0.14 −17.35 +6.44 
Values are mean±SEM for n=5. + denotes higher by; − denotes lower by. Difference considered statistically significant at p<0.05 and a 
relative change of ten (10) per cent and above [42]. 
As shown in Table 3, the malondialdehyde concentration (mg/ml) in the serum of rats exposed to AL 
therapeutic dose, group B (0.55±0.08 mg/ml, +30.95 %) was higher (P<0.05) compared to the control 
group (0.42±0.02 mg/ml). The MDA concentration in the serum of rats exposed to AL overdose, group 
C (0.47±0.03mg/ml), intoxicating dose of MSG, group D (0.47±0.01 mg/ml) and AL overdose together 
with intoxicating dose of MSG, group F (0.45±0.02 mg/ml) was higher but not significant (P>0.05) as 
compared to the control rats. However, the MDA concentration in the serum of rats exposed to AL 
therapeutic dose together with intoxicating dose of MSG, group E (0.42±0.02 mg/ml) was similar to that 
of the control. 
Table 3: Malondialdehyde concentration (mg/ml) in the serum of normal and monosodium glutamate-
intoxicated rats co-treated with artemether-lumefantrine 
Group MDA (mg/ml) 
Changes relative to the 
control (%) 
Changes relative to the 
MSG group (%) 
A: Control (feed + water only) 0.42±0.02 0.00 −10.64 
B: AL therapeutic dose 0.55±0.08 +30.95 +17.02 
C: AL overdose 0.47±0.03 +11.90 0.00 
D: MSG (8000mgkg-1bwt) 0.47±0.01 +11.90 0.00 
E: AL therapeutic dose + MSG 0.42±0.02 0.00 −10.64 
F: AL overdose + MSG 0.45±0.02 +7.14 −4.26 
Values are mean±SEM for n=5. + denotes higher by; − denotes lower by. Difference considered statistically significant at p<0.05 and a 
relative change of ten (10) per cent and above [42]. 
The MDA concentration in the liver homogenate of rats exposed to AL therapeutic dose, group B 
(0.62±0.05 mg/ml) and to intoxicating dose of MSG, group D (0.63±0.02 mg/ml) was higher (P<0.05) 
than that of the control group (0.52±0.05 mg/ml). However, the MDA concentration in the rats exposed 
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to AL overdose together with intoxicating dose of MSG, group F (0.45±0.04 mg/ml) was lower (P<0.05) 
than that of control and other groups (Table 4). 
Table 4: Malondialdehyde concentration (mg/ml) in the liver homogenate of normal and monosodium 
glutamate-intoxicated rats co-treated with artemether-lumefantrine 
Group MDA (mg/ml) Changes relative to the 
control (%) 
Changes relative to the 
MSG group (%) 
A: Control (feed + water only) 0.52±0.05 0.00 −17.46 
B: AL therapeutic dose 0.52±0.05 0.00 −17.46 
C: AL overdose 0.51±0.03 −1.92 −19.05 
D: MSG (8000mgkg-1bwt) 0.63±0.02 +21.15 0.00 
E: AL therapeutic dose + 
MSG 
0.52±0.04 0.00 −17.46 
F: AL overdose + MSG 0.45±0.04 −13.46 −28.57 
Values are mean±SEM for n=5. + denotes higher by; − denotes lower by. Difference considered statistically significant at p<0.05 and a 
relative change of ten (10) per cent and above [42]. 
From Table 5, albumin concentration in the serum of rats exposed to intoxicating dose of MSG, group D 
(2.59±0.13 g/dl), AL overdose together with intoxicating dose of MSG, group F (3.24±0.12 g/dl), and AL 
therapeutic dose together with intoxicating dose of MSG, group E (2.31±0.09 g/dl) was higher (P<0.05) 
than that of the control (2.02±0.04 g/dl). The albumin concentration in the serum of rats exposed to AL 
therapeutic dose, group B (1.95±0.10 g/dl) was lower (P>0.05) while that for the rats exposed to AL 
overdose, group C (2.09±0.42 g/dl) was higher (P>0.05) compared to the control (2.02±0.04 g/dl). 
Table 5: Albumin concentration (g/dl) in the serum of normal and monosodium glutamate-intoxicated rats co-
treated with artemether-lumefantrine 
Group Albumin (g/dl) Changes relative to the 
control (%) 
Changes relative to the 
MSG group (%) 
A: Control (feed + water only) 2.02±0.04 0.00 −22.01 
B: AL therapeutic dose 1.95±011 −3.47 −24.71 
C: AL overdose 2.09±0.04 +3.47 −19.31 
D: MSG (8000mgkg-1bwt) 2.59±0.13 +28.22 0.00 
E: AL therapeutic dose + MSG 2.31±0.09 +14.36 −10.81 
F: AL overdose + MSG 3.24±0.12 +60.40 +25.10 
Values are mean±SEM for n=5. + denotes higher by; − denotes lower by. Difference considered statistically significant at p<0.05 and a 
relative change of ten (10) per cent and above [42]. 
Table 6: Albumin concentration (g/dl) in the liver homogenate of normal and monosodium glutamate-
intoxicated rats co-treated with artemether-lumefantrine 
Group Albumin (g/dl) Changes relative to the 
control (%) 
Changes relative to the 
MSG group (%) 
A: Control (feed + water only) 1.36±0.12 0.00 +16.24 
B: AL therapeutic dose 1.19±0.05 −12.50 +1.71 
C: AL overdose 1.37±0.05 +0.74 +17.09 
D: MSG (8000mgkg-1bwt) 1.17±0.06 −13.97 0.00 
E: AL therapeutic dose + MSG 1.20±0.04 −11.76 +2.56 
F: AL overdose + MSG 1.34±0.05 −1.47 +14.53 
Values are mean±SEM for n=5. + denotes higher by; − denotes lower by. Difference considered statistically significant at p<0.05 and a 
relative change of ten (10) per cent and above [42]. 
As depicted in Table 6, the albumin concentration in the liver homogenate of rats exposed to intoxicating 
concentration of MSG, group D (1.17±0.06g/dl), AL therapeutic dose, group B (1.19±0.04 g/dl) and AL 
therapeutic dose together with intoxicating dose of MSG, group E (1.20±0.03 g/dl) was lower (P<0.05) 
than that of rats in the control (1.36±0.12 g/dl). However, the albumin concentration in the liver 
homogenate of rats exposed to AL overdose, group C (1.37±0.04 g/dl) was higher (P>0.05) but lower 
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(P>0.05) in the rats exposed to AL overdose together with intoxicating dose of MSG (1.34±0.05 g/dl) 
compared to the control (1.36±0.12 g/dl). 
The result as shown on Table 7 revealed that in the serum of the rats, the Total protein : Albumin ratio was 
the least while the Albumin : total protein ratio was the highest, respectively in the rats exposed to MSG 
(1.44 (0.70); representing a decrease by 37.39 and increase by 62.79) followed by that of rats exposed to AL 
overdose + MSG (1.45(0.69); 36.96(60.47)) and AL overdose (1.59(0.63); 30.87(46.51)) when compared 
with the control. 
Table 7: Total protein: Albumin (total protein: Albumin) ratio in the serum of normal and monosodium 
glutamate-intoxicated rats co-treated with artemether-lumefantrine 
Group Total protein:Albumin 
(Albumin: total protein) 
Changes relative to 
the control (%) 
Changes relative to the 
MSG group (%) 
A: Control (feed + water 
only) 
2.30(0.43) 0.00(0.00) +59.72(−38.57) 
B: AL therapeutic dose 1.86(0.54) −19.13(+25.58) +29.17(−22.86) 
C: AL overdose 1.59(0.63) −30.87(+46.51) +10.42(−10.00) 
D: MSG (8000mgkg-1bwt) 1.44(0.70) −37.39(+62.79) 0.00(0.00) 
E: AL therapeutic dose + 
MSG 
1.86(0.54) −19.13(+25.58) +29.17(−22..86) 
F: AL overdose + MSG 1.45(0.69) −36.96(+60.47) +0.69(−1.43) 
Values are inverse (and converse) ratios of parameters in this study; + denotes higher by; - denotes lower by. Difference considered 
statistically significant for relative change value of ten (10) per cent and above [42]. 
The result as shown on Table 8 revealed that in the liver homogenate of the rats, the Total protein : Albumin 
ratio decreased the most while the Albumin : total protein ratio increased the most, respectively in the rats 
exposed to AL overdose + MSG (-16.00(20.00)) followed by that of rats exposed to AL overdose (-
11.60(12.50) and MSG (-9.60(10.00) when compared with the control. 
Table 8: Total protein: Albumin (Albumin: total protein) ratio in the liver homogenate of normal and 
monosodium glutamate-intoxicated rats co-treated with artemether-lumefantrine 
Group Total protein: Albumin 
(Albumin: total protein) 
Changes relative to 
the control (%) 
Changes relative to the 
MSG group (%) 
A: Control (feed + water only) 2.50(0.40) 0.00(0.00) +10.62(−9.09) 
B: AL therapeutic dose 3.45(0.29) +38.00(−27.50) +52.65(−40.91) 
C: AL overdose 2.21(0.45) −11.60(+12.50) −2.21(+2.27) 
D: MSG (8000mgkg-1bwt) 2.26(0.44) −9.60(+10.00) 0.00(0.00) 
E: AL therapeutic dose + MSG 2.53(0.39) +1.20(−2.50) +11.95(−11.36) 
F: AL overdose + MSG 2.10(0.48) −16.00(+20.00) −7.08(+9.09) 
Values are inverse (and converse) ratios of parameters in this study; + denotes higher by; - denotes lower by. Difference considered 
statistically significant for relative change value of ten (10) per cent and above [42]. 
4 Discussion 
MSG could alter energy balance in animals with possible health consequences (44) while artemether-
lumefantrine (AL) and monosodium glutamate (MSG), respectively mediated oxidative stress which is 
fundamental in diseased conditions [25, 26]. Recently, normal rats exposed to overdose of AL together with 
MSG had compromised liver morphology and antioxidant capacity [28]. Altered liver bio-function could 
be detrimental to balanced physio-function. In particular, malondialdehyde, could react on cellular and 
tissue proteins to form adduct resulting to the alteration of protein function and attendant cellular responses 
[29], warranting this study. The result showed markedly lowered (P<0.05) total protein concentration 
(g/dL) in the liver homogenate of rats exposed to MSG (group D) or MSG plus AL overdose (group F), 
compared to other groups. The observation could be attributed to compromised liver integrity or function 
resulting to or from adverse influence on protein metabolism cum function in the group of rats [45]. Proteins 
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are essentially produced in and secreted by hepatocytes (liver cells) [46] and lowered protein concentration 
could reflect impaired liver integrity following enhanced adduct formation with malondialdehyde [47].Thus, 
compromised protein synthesis or enhanced protein catabolism, including up-regulated protein-
malondialdehyde adduct formation following possibly compromised liver integrity and bio-functions could 
result to reduced protein concentration as observed in the present study. The observation was significant 
and marked in the liver homogenate of rats exposed to MSG either alone (group D) or together with an 
overdose of AL (group F) (Table 2).This, in apparent support of earlier study [28], underscored a marked 
adverse influence of concomitant exposure of MSG and overdose of AL on the liver integrity and liver-
mediated protein metabolism and bio-functions, including possibly enhanced protein-malondialdehyde 
adduct formation, in non-malarial-infested rats. 
Similarly, the MDA concentration (mg/ml) in the liver homogenate of rats exposed to overdose of AL 
together with MSG (0.45±0.04 mg/ml) was lower (P<0.05) than that of the control and other groups, 
seemingly supporting the inferred possibly enhanced protein-malondialdehyde adduct formation as likely 
mechanism leading to the observed reduction in protein concentration in the studied samples. In particular, 
the observation and the bio-consequence could be overriding in the liver of rats concomitantly exposed to 
AL overdose and MSG. Prevailing MDA concentration in biologic sample could be diagnostic [48]. Cellular 
and tissue proteins-related malondialdehyde adduct formation could result in protein dysfunction and 
attendant alteration in cellular responses [29,49]. Thus, reduction in malondialdehyde concentration could 
be as a consequence of compromised antioxidant status of the rats [28] and its (MDA) possibly enhanced 
reaction with cellular and tissue proteins which probably explained the co-consequent reduction in total 
protein concentration of the rats as observed in this study. The reduction in MDA concentration seemingly 
confirms earlier reports of significant decrease in the antioxidants parameters due to an induction of 
oxidative stress by monosodium glutamate [26,28], which overwhelmed the rats antioxidants capacity 
resulting to the depletion [50] as observed. MSG-related lipid peroxidation on the liver leading to liver 
damage has been reported [49]. Thus, the apparent interactive effect of overdose of AL together with 
overdose of MSG could be synergistic and detrimental on the MDA concentration and associated bio-
functions in, notably, the liver of rats. However, the albumin concentration (mg/ml) in rats exposed to 
MSG alone (2.59±0.13 g/dl) or to an overdose of AL together with MSG (3.24±0.12 g/dl), compared to 
the control (2.02±0.04 g/dl), was higher (P<0.05) in the serum, indicating apparent diminution in albumin 
elimination due perhaps to renal excretory dysfunctions [38]. On the other hand, the albumin concentration 
in the liver homogenate of rats exposed to MSG (1.17±0.06 g/dl), therapeutic dose of AL (1.19±0.04 g/dl) 
and therapeutic dose of AL together with MSG (1.20±0.03 g/dl) was lower (P<0.05) than that of rats in 
the control (1.36±0.12 g/dl), indicating apparently enhanced free radical generation-related adverse 
response in the rats [50].Albumin is essentially prominent binding cum transport protein, and low 
concentration could be due to its antioxidant activity [51] aside protein loss in nephrotic syndrome as well 
as decreased synthesis and negative fluid imbalance as in chronic liver impairment [52]. 
Appropriate ratios of the studied bio-indicators could be prognostic[53].In the serum and liver homogenate 
of the rats, the total protein : albumin ratio was lower while the albumin : total protein ratio was higher, 
respectively in the rats exposed to MSG, Overdose of AL + MSG or overdose of AL when compared with 
the control. The observation could be a pointer to hitherto unknown underlying pathology as recently low 
albumin/globulin ratio was significantly associated with poor overall survival in various cancers [54] while 
a low albumin to globulin ratio was a prognostic marker for poor survival in cervical cancer patients [55]. 
Generally, the non-significant (P>0.05) and inconsistent responses in some groups, is not surprising. At 
therapeutic dose, AL was reportedly well-tolerated with negligible side response [56], while the intoxicating 
dose of MSG at short exposure duration as in this study (7 days) may not have caused observable toxicity 
in the rats’ samples. The inconsistent result in the serum and liver homogenate samples could be attributed 
to the long circulatory half-life of albumin [57] and commonly known high volatility of lipid peroxidation 
products, including MDA vis a vis the possibly higher antioxidant activity in the liver implying unequal 
utilization hence unequal balance of the determined bio-indicators in the two samples as observed. 
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Furthermore, induction of oxidative stress leading to liver tissue damage may occur despite apparent 
beneficial or insignificant alteration in antioxidant markers [24]. Howbeit, these (non-significant and 
inconsistent observations) are significant limitation of the present study. Further studies aimed at 
eliminating the noted limitations could provide useful insight on the studied area, hence are warranted. 
5 Conclusion 
Thus, the apparent MSG plus AL overdose-induced adverse influence on the studied parameters and 
samples of non-malarial infested rats could be via compromised liver-mediated protein metabolism capacity 
and bio-functions following possibly enhanced protein-malondialdehyde adduct formation in the rats. 
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